| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |